IBCSG Trial 22-00 Serum Substudy

计划入组 136 人 · 首次发布于 2015 年 3 月 19 日

Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers

计划入组 9 人 · 首次发布于 2006 年 2 月 14 日

Research for clinical validation of HER2 protein overexpression and gene amplification assay for salivary gland carcinoma

计划入组 26 人

IL2/IL-10-anti-Ebola/HER2 Antibody fusion proteins(Deka Biosciences)

Her2-DIDT

Her2-IACS8803

Protein Sciences Corporation

United States

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Arvinas

United States

Engineered Antibody Precisely Targets Mutant HER2 in Cancer Cells

HER2-Positive Gastric Cancer Pipeline Shows Robust Activity with 20+ Companies Developing Novel Therapies

ExpreS2ion's ES2B-C001 HER2-Targeting Vaccine Approved for Phase I Trial in Breast Cancer